160 related articles for article (PubMed ID: 1246850)
1. [Pyridinolcarbamate treatment of ischemic heart disease].
Kuz'ko NV
Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
[No Abstract] [Full Text] [Related]
2. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
Valiensi M; Riboli E; Lombardi M
Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
[No Abstract] [Full Text] [Related]
3. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
Citarrella P; Abbadessa V; Pecorella M; Cajozzo A
Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239
[No Abstract] [Full Text] [Related]
4. [Activity of the kallikrein-kinin system in patients with ischemic heart disease treated with parmidine].
Vygovskiĭ VP; Zaremba EF; Podil'chak EM; Dutka RIa; Gorgota OV
Vrach Delo; 1985 Sep; (9):6-8. PubMed ID: 2416131
[No Abstract] [Full Text] [Related]
5. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
[No Abstract] [Full Text] [Related]
6. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
[No Abstract] [Full Text] [Related]
7. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
Sobczyk W; Kruszewska J; Szymchel J
Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
[TBL] [Abstract][Full Text] [Related]
8. [Mechanism of action and clinical effectiveness of the new Soviet-made drug parmidin in the treatment of arteriosclerosis and ischemic heart disease].
Kukes VG; Mashkovskiĭ MD; Paskhina TS; Borisov VG; Shvarts GIa
Kardiologiia; 1978 Oct; 18(10):61-8. PubMed ID: 213636
[TBL] [Abstract][Full Text] [Related]
9. Clinical and laboratory examinations with Prodectin.
Bédi J; Kosztovics A; Pálos LA
Ther Hung; 1976; 24(3):91-7. PubMed ID: 1013926
[No Abstract] [Full Text] [Related]
10. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
Majkowski J; Lysakowska-Sernicka K; Gajewska A; Bilińska-Nigot B; Ostrowski K; Semenicki K
Neurol Neurochir Pol; 1978; 12(4):387-96. PubMed ID: 714218
[TBL] [Abstract][Full Text] [Related]
11. [Effect of prodectin and lipoic acid on the lipid metabolism indicators in chronic ischemic heart disease].
Grigor'ian VA; Klantsa NA; Prishliak VD; Klantsa PN
Vrach Delo; 1981 Oct; (10):13-5. PubMed ID: 6795820
[No Abstract] [Full Text] [Related]
12. [Clinical and rheoencephalographical evaluation of prodectin in the treatment of cerebral arteriosclerosis].
Wysocka-Bakowska MM
Neurol Neurochir Pol; 1981; 15(4):431-36. PubMed ID: 7035991
[TBL] [Abstract][Full Text] [Related]
13. Pyridinolcarbamate in the long-term treatment of ischaemic heart disease.
Gulyás A; Szám I
Ther Hung; 1976; 24(2):63-6. PubMed ID: 982341
[No Abstract] [Full Text] [Related]
14. [Value of pyridinol carbamate in ocular vascular pathology (Angioxine)].
Boudet ; Millet ; Arnaud
Bull Soc Ophtalmol Fr; 1974; 74(9-10):977-80. PubMed ID: 4470033
[No Abstract] [Full Text] [Related]
15. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
Fisanovich TI; Tolstova LG
Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
[No Abstract] [Full Text] [Related]
16. [Prodectin treatment of partial hearing loss as a result of atherosclerosis].
Smirnova NA; Timakov VA; Mikushkin MK
Vestn Otorinolaringol; 1982; (6):53-6. PubMed ID: 7179649
[No Abstract] [Full Text] [Related]
17. Attempts to delay progression in occlusive atherosclerosis.
Terry EN; Rouen LR; Clasuss RH; Katz MC; Redisch W
Ann N Y Acad Sci; 1976; 275():379-85. PubMed ID: 1070279
[No Abstract] [Full Text] [Related]
18. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
Roztocil K; Oliva I; Linhart J; Prerovský I; Modr Z
Cas Lek Cesk; 1976 Aug; 115(33-34):1051-5. PubMed ID: 975177
[No Abstract] [Full Text] [Related]
19. The use of prodectin in the treatment of cerebral arteriosclerosis and its complications.
Abrányi I; Máté
Ther Hung; 1976; 24(1):20-3. PubMed ID: 790631
[No Abstract] [Full Text] [Related]
20. [Contribution of angioxine to the vascular protection of the diabetic].
Journ Annu Diabetol Hotel Dieu; 1976 May; ():319-27. PubMed ID: 796526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
